The Regional Gene Therapy Liaison (RGTL) is a highly motivated, field-based sales professional responsible for supporting the promotion and commercialization of Vyjuvek, a non-invasive topical gene therapy for patients with dystrophic epidermolysis bullosa (DEB). The role covers Texas, Oklahoma, Missouri, Arkansas, and Kansas, and focuses on market development across multiple territories. The RGTL partners with healthcare professionals to identify needs and compliantly educate stakeholders about Vyjuvek, while representing the voice of the customer to internal teams. This is a highly field-intensive role requiring at least 75% travel. The successful candidate will build trust with internal and external stakeholders, contribute to regional and territory objectives, and bring energy to the dermatology community and other specialties involved in DEB diagnosis, management, and treatment. The position requires a patient-first, collaborative approach; strategic thinking; strong time management; integrity; professionalism; and adherence to corporate and industry compliance standards. This is an at-will, full-time, benefits-eligible position with an initial fixed term of six months. Continued employment beyond the initial term, including extension or conversion to a full-time role, will be considered based on individual performance and business needs but is not guaranteed.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level